Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as NOT CERTIFIED by the ABIM in the specialty he practices and teaches (hematology). When he called the ABIM, he was told he needed to pay thousands of dollars in back fees for the Internal Medicine Board that he did not want to keep, as he is a specialist in bone marrow transplant and hematology.
The ABIM advised that unless he pays these fees, he will be deemed “not certified,” which threatens his ability to see patients at his own institution. Aaron was shocked and so was I. Learn what happened, what is next, and what can be done.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
